The Potential Impact of Clindamycin on Neurosurgery Patients.

Summary

A prospective, open-label, single center, controlled trial. 44 patients that underwent neurosurgery or presented meningitis signs, for whom Clindamycin add-on therapy to assess its effect on neurological complication in relation to Neuron-specific enolase (NSE) and Neurotensin biomarkers levels.

Timeline

Start

2023-03-01

Primary completion

2023-12-01

Completion

2023-12-30

Drugs

Indications